GINKGO BIOWORKS HOLDINGS, INC. Equity Method Investment, Other than Temporary Impairment
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Equity Method Investment, Other than Temporary Impairment of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-02-26
- GINKGO BIOWORKS HOLDINGS, INC. equity method investment, other than temporary impairment for fiscal 2025 was $0.00.
- GINKGO BIOWORKS HOLDINGS, INC. equity method investment, other than temporary impairment for fiscal 2024 was $0.00.
- GINKGO BIOWORKS HOLDINGS, INC. equity method investment, other than temporary impairment for fiscal 2023 was $0.00.
- GINKGO BIOWORKS HOLDINGS, INC. equity method investment, other than temporary impairment for fiscal 2022 was $0.00.
| Period end | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-25 |